TricorPAT

Scientifically validated patented device for the treatment of male and female androgenetic alopecia and hair thinning issues. Developed utilizing the esteemed Italian tricogenesus protocol with 2 world patents, and endorsed by the dermatological team at the University of Bologna, this innovative approach combines the simultaneous action of the controlled microdermo-incision and the pressure wave technologies to obtain different dynamic-restructuring actions to increase oxygenation of the tissues, to stimulate the cellular metabolism and the vehiculation of the active ingredients.  These active ingredients are mixture of growth factors, administered via iontophoresis directly to the hair roots to effectively reduce hair loss and promote thicker, healthier hair across all treated areas.